EVOGENE LTD (EVGN)
IL0011050551 - Common Stock
EVOGENE LTD
NASDAQ:EVGN (11/21/2024, 7:20:17 PM)
After market: 1.55 -0.05 (-3.12%)1.6
-0.05 (-3.03%)
Company Profile
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Company Info
EVOGENE LTD
13 Gad Feinstein Street, Park Rehovot
Rehovot 7414002
P: 97289311900
CEO: Ofer Haviv
Employees: 141
Website: https://evogene.com/
EVGN News
13 hours ago - EvogeneEvogene Reports Third Quarter 2024 Financial ResultsConference call and webcast: today, November 21, 2024, 9:00 am ET Financial Highlights: In the first nine months of 2024, total revenues reached approximately...
3 days ago - Lavie BioLavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results/PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced significant...
8 days ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.Top movers in Wednesday's after hours session
10 days ago - Lavie BioLavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials/PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced the commercial...
15 days ago - EvogeneEvogene Schedules Third Quarter 2024 Financial Results Release/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...
20 days ago - ChartmillThe trading volume of these stocks is deviating from the norm in today's session.The trading volume of these stocks is deviating from the norm in today's session.
EVGN Twits
Here you can normally see the latest stock twits on EVGN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
